Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients
Authors:
- Pierangelo ChinelloPCPierangelo Chinello
- Francesco P. LisenaFLFrancesco P. Lisena
- Claudio AngelettiCAClaudio Angeletti
- Evangelo BoumisEBEvangelo Boumis
- Federica PapettiFPFederica Papetti
- Nicola PetrosilloNicola Petrosillo
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 54 (6) , 597-602
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ciprofloxacin-induced torsade de pointesInternational Journal of Cardiology, 2006
- Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patientsJournal of Electrocardiology, 2006
- Ciprofloxacin-induced acquired long QT syndromeHeart Rhythm, 2004
- Qt prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadoneThe American Journal of Cardiology, 2003
- Efavirenz-Associated QT Prolongation and Torsade de Pointes ArrhythmiaAnnals of Pharmacotherapy, 2002
- Long QTc and Torsades de Pointes in Human Immunodeficiency Virus DiseasePacing and Clinical Electrophysiology, 1997
- Prolongation of the QTc Interval in African Children Treated for Falciparum MalariaThe American Journal of Tropical Medicine and Hygiene, 1997
- Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infectionClinical Autonomic Research, 1995
- Incidence of Cardiac Arrhythmias During Intravenous Pentamidine Therapy in HIV-Infected PatientsChest, 1994
- QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazoleThe American Journal of Cardiology, 1987